Clincosm LogoSign in Get a demo

Prescription Audit in OPD of NABH & JCI Approved Hospital in Capital Territory of India

Sponsor
Kakatiya University (Other)
Overall Status
Completed
CT.gov ID
NCT05729412
Collaborator
(none)
100
Enrollment
1
Location
2
Actual Duration (Months)
49.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient.

Need of study:

For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve quality standards and quality of care For implication of professional practices To identify and eliminate deficient practice

Objectives:

  1. To study the quality of good prescription

  2. In minimization of prescription errors and medication errors

  3. Also to comply with good clinical practice

  4. Enhancement of patient safety

  5. In the maintenance of rational prescribing

  6. To study the quality of care provided by the hospital to the patient

Plan of study:

  • To select the patient based on inclusion and exclusion criteria

  • To collect the information from OP's prescription

  • To identify prescribing errors and medication error

  • To study the management of good prescription

Study Sites: Max Super Speciality Hospital, Saket, New Delhi (INDIA) Study Design:

Observational cohort study Study Duration: 1 month (November 2022)

Condition or Disease Intervention/Treatment Phase
  • Other: Mentioned

Detailed Description

Source of the data: Review of out-patient prescription Sample size: 100 prescription

Possible outcomes:

Minimization of prescribing errors It improves the quality of care Enhancement of patient safety Compliance with good clinical practice In the maintenance of rational prescribing

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Prescription Audit In The Outpatient Department Of Nabh & Jci Approved Super Speciality Hospital In The Capital Territory Of India
Actual Study Start Date :
Nov 1, 2022
Actual Primary Completion Date :
Jan 1, 2023
Actual Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Compliance

Prescription is filled for specific parameters

Other: Mentioned
If prescription is properly filled for specific details than it is compliance
Other Names:
  • Prescription is properly filled

    		•
    Non-compliance

    Prescription is not filled for specific parameters

    Other: Mentioned
    If prescription is properly filled for specific details than it is compliance
    Other Names:
  • Prescription is properly filled

    		•
    Not available - NA

    Data not available

    Other: Mentioned
    If prescription is properly filled for specific details than it is compliance
    Other Names:
  • Prescription is properly filled

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of prescription [November 01, 2022 to November 30, 2022]

      Data is available sufficient

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria: Participants who are willing to participate. Participants who are attending in the out-patient department. Participants reported during the study period. Participants who have a prescription which is legible and complete.

    Exclusion Criteria: Participants who are unwilling to provide the required information. Participants who are not attending the out-patient department. Participants whose prescription is not legible and competent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Max Super Speciality Hospital New Delhi Delhi India 110017

    Sponsors and Collaborators

    • Kakatiya University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Satyam Suman, Clinical Pharmacy Department, Kakatiya University
    ClinicalTrials.gov Identifier:
    NCT05729412
    Other Study ID Numbers:
    • MAX/IEC/2022/NOV/PA01
    First Posted:
    Feb 15, 2023
    Last Update Posted:
    Feb 15, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Satyam Suman, Clinical Pharmacy Department, Kakatiya University
    Medical Audit
    Prescription Audit
    Gender difference

    Study Results

    No Results Posted as of Feb 15, 2023